Table 2.

Baseline Symptom Severity

Placebo (n = 84)Atomoxetine (mg/kg/day)
0.5
(n = 44)
1.2
(n = 84)
1.8
(n = 85)
ADHD RS total score38.3 (8.9)40.2 (9.6)39.2 (9.2)39.7 (8.7)
ADHD RS inattentive21.4 (4.0)22.4 (3.6)22.2 (4.0)22.1 (4.2)
ADHD RS hyperactive/impulsive16.9 (6.6)17.8 (7.4)16.9 (7.1)17.6 (6.2)
CPRS-R ADHD27.3 (6.3)30.7 (4.4)28.0 (5.6)27.9 (6.7)
CPRS-R hyperactive10.3 (4.9)12.0 (4.8)10.2 (5.1)10.6 (4.6)
CPRS-R cognitive14.0 (3.7)16.0 (2.5)14.4 (3.2)14.4 (4.0)
CPRS-R oppositional9.1 (5.0)11.0 (4.4)9.6 (4.6)10.3 (4.8)
CGI-S4.7 (0.8)4.8 (0.9)4.8 (0.9)4.9 (0.7)
CDRS-R24.8 (8.0)26.3 (7.3)25.3 (7.3)27.1 (8.0)
CHQ
Psychosocial summary
 Score35.2 (11.4)32.9 (9.6)35.4 (10.4)31.3 (10.6)
 Behavior47.2 (19.7)43.2 (17.2)44.8 (19.1)41.0 (16.2)
 Family activity58.3 (23.9)44.5 (22.1)52.1 (24.9)48.9 (26.0)
 Parent impact–emotional48.1 (22.6)46.5 (17.6)48.4 (17.0)44.4 (19.3)
 Parent impact–time67.2 (23.2)64.4 (23.5)69.3 (22.2)64.0 (23.5)
 Mental health72.5 (17.7)68.1 (17.1)72.9 (13.9)66.6 (16.0)
 Emotional role67.6 (33.2)60.8 (39.6)67.6 (35.3)61.0 (34.2)
  • All values are mean (SD) change from baseline to endpoint.